PL2330892T3 - Sposoby leczenia z zastosowaniem leków wychwytujących amoniak - Google Patents

Sposoby leczenia z zastosowaniem leków wychwytujących amoniak

Info

Publication number
PL2330892T3
PL2330892T3 PL09739263T PL09739263T PL2330892T3 PL 2330892 T3 PL2330892 T3 PL 2330892T3 PL 09739263 T PL09739263 T PL 09739263T PL 09739263 T PL09739263 T PL 09739263T PL 2330892 T3 PL2330892 T3 PL 2330892T3
Authority
PL
Poland
Prior art keywords
medications
ammonia
treatment
methods
Prior art date
Application number
PL09739263T
Other languages
English (en)
Inventor
Bruce Scharschmidt
Original Assignee
Horizon Therapeutics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Therapeutics, Llc filed Critical Horizon Therapeutics, Llc
Publication of PL2330892T3 publication Critical patent/PL2330892T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL09739263T 2008-08-29 2009-01-07 Sposoby leczenia z zastosowaniem leków wychwytujących amoniak PL2330892T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9323408P 2008-08-29 2008-08-29

Publications (1)

Publication Number Publication Date
PL2330892T3 true PL2330892T3 (pl) 2017-05-31

Family

ID=45604478

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09739263T PL2330892T3 (pl) 2008-08-29 2009-01-07 Sposoby leczenia z zastosowaniem leków wychwytujących amoniak

Country Status (10)

Country Link
JP (3) JP5577341B2 (pl)
DK (1) DK3133396T3 (pl)
ES (2) ES2695534T3 (pl)
HR (2) HRP20161222T1 (pl)
HU (2) HUE040503T2 (pl)
LT (2) LT3133396T (pl)
PL (1) PL2330892T3 (pl)
PT (2) PT3133396T (pl)
SI (1) SI3133396T1 (pl)
TR (1) TR201816616T4 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2760479T3 (en) 2011-09-30 2017-07-17 Horizon Therapeutics Llc Nitrogen-removing drug for use in a method of treating a nitrogen retention disorder
CN104540507A (zh) * 2012-04-20 2015-04-22 海波龙治疗公司 苯乙酸前药的治疗性监测方法
US9289406B2 (en) * 2012-11-21 2016-03-22 Horizon Therapeutics, Inc. Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
EP3782610A1 (en) 2013-11-14 2021-02-24 Ultragenyx Pharmaceutical Inc. Solid compositions of triglycerides and uses tehreof
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
JP6797456B2 (ja) * 2018-10-04 2020-12-09 アトナープ株式会社 生体情報取得システム、健康管理サーバーおよびシステム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
DE69612755T2 (de) * 1995-02-07 2001-08-23 Brusilow Enterprises, Llc Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate

Also Published As

Publication number Publication date
PT3133396T (pt) 2018-12-07
ES2593378T3 (es) 2016-12-09
JP5577341B2 (ja) 2014-08-20
HUE029912T2 (en) 2017-03-28
HUE040503T2 (hu) 2019-03-28
JP2012501451A (ja) 2012-01-19
ES2695534T3 (es) 2019-01-08
PT2330892T (pt) 2016-09-05
LT2330892T (lt) 2016-11-25
DK3133396T3 (en) 2018-12-03
LT3133396T (lt) 2018-11-26
SI3133396T1 (sl) 2018-12-31
TR201816616T4 (tr) 2018-11-21
JP2012501329A (ja) 2012-01-19
HRP20181877T1 (hr) 2019-01-11
JP2014102255A (ja) 2014-06-05
HRP20161222T1 (hr) 2017-02-10

Similar Documents

Publication Publication Date Title
NO2024044I1 (no) Insulin icodec
PL3133396T3 (pl) Sposób leczenia z zastosowaniem leków wychwytujących amoniak
EP2296593A4 (en) MEDICAL HEAD COVER
BRPI0910854A2 (pt) métodos de tratamento
DK2330887T3 (da) Behandlingsindretning
PL3476371T3 (pl) Urządzenie do leczenia gerd
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
DK2337597T3 (da) Medicinsk injektor med koblede legemsenheder
DK2300609T3 (da) Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
BRPI0910259A2 (pt) métodos de tratamento de inflamação
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
HUE045367T2 (hu) Kombinált terápia diabétesz kezelésére
BRPI0915822A2 (pt) dispositivo médico
DK2173831T3 (da) Brøndbehandling
DK3150178T3 (da) Stimuleringsapparat
EP3381471C0 (en) PAIN TREATMENT
DK2265296T3 (da) Medicinske apparater med hydrofile belægninger
BRPI0822129A2 (pt) Inibidores de aldh-2c no tratamento de vício.
PL2330892T3 (pl) Sposoby leczenia z zastosowaniem leków wychwytujących amoniak
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0806944A2 (pt) Medicamento para o tratamento de endometriose
DK2346559T3 (da) Medicinsk anordning
AT506244A3 (de) Verbindungskörper
FI20086065L (fi) Lukkorunko
FR2937843B1 (fr) Paravent medical